{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:04:40Z","timestamp":1790147080365,"version":"4.0.1"},"reference-count":27,"publisher":"Informa UK Limited","issue":"13","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2026,9,2]]},"DOI":"10.1080\/14656566.2026.2721561","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:04:38Z","timestamp":1788451478000},"page":"1417-1422","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating bezuclastinib for the treatment of advanced gastrointestinal stromal tumours"],"prefix":"10.1080","volume":"27","author":[{"given":"Antoine","family":"Italiano","sequence":"first","affiliation":[{"name":"DITEP, Gustave Roussy","place":["Villejuif, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2015.10.031"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.09.005"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/17588359231192388"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020461"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.2099"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30269-2"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00318-8"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69446-4"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.02.011"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61857-1"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30168-6"},{"key":"e_1_3_4_14_1","unstructured":"Australian Government Department of Health Disability and Ageing. Medicines for the treatment of gastrointestinal stromal tumours: drug utilisation sub-committee public release document. 2025 Apr [cited 2026 Aug 13]. Available from: https:\/\/www.pbs.gov.au\/industry\/listing\/participants\/public-release-docs\/2025-04\/Medicines-for-GIST-DUSC-PRD-2025-04-final.PDF"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.05.518"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1211"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.2382"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00294"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02734-5"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2026.44.16_suppl.TPS11588"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2026.44.16_suppl.11500"},{"key":"e_1_3_4_22_1","unstructured":"Cogent Biosciences. Detailed clinical data from the PEAK phase 3 trial with bezuclastinib in combination with sunitinib in gastrointestinal stromal tumors at the 2026 ASCO annual meeting. Press release. 2026 May 30 [cited 2026 Aug 13]. Available from: https:\/\/investors.cogentbio.com\/news-releases\/news-release-details\/cogent-biosciences-announces-detailed-clinical-data-peak-phase-3"},{"key":"#cr-split#-e_1_3_4_23_1.1","unstructured":"Cogent Biosciences Inc. Quarterly report for the period ended 30 June 2026. Form 10-Q. Filed"},{"key":"#cr-split#-e_1_3_4_23_1.2","unstructured":"2026 Aug 10 [cited 2026 Aug 13]. Available from: https:\/\/www.sec.gov\/Archives\/edgar\/data\/1622229\/000119312526342393\/cogt-20260630.htm"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.2086"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2022-147"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-018-0541-2"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.11537"},{"key":"e_1_3_4_28_1","unstructured":"Barnett B Rosinovsky E Sahin H et al. Bezuclastinib formulations. International patent application WO2024138005A1. Published 2024 Jun 27. [cited 2026 Aug 13]. Available from: https:\/\/patents.google.com\/patent\/WO2024138005A1\/en"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2026.2721561","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14656566.2026.2721561","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2026.2721561","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:49:37Z","timestamp":1790146177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2026.2721561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":27,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,9,2]]}},"alternative-id":["10.1080\/14656566.2026.2721561"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2026.2721561","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-07-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}